"VITALINK’S FULLY INTEGRATED NETWORK OF CLINICAL TRIALS SITES connects renowned physicians and medical professionals with site managers and coordinators to create a seamless trial experience that puts the patient first and produces trustworthy and consistent results"

During the past decade, VitaLink Research - Easley conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "VitaLink Research - Easley" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator and "LGC Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "VitaLink Research - Easley" are "COPD" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "VitaLink Research - Easley" in a lesser frequency.

Most popular intervention types in "VitaLink Research - Easley" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ensifentrine (formerly RPL554) 0.375 mg twice daily plus placebo, in addition to tiotropium" (1 trials), "Ensifentrine (formerly RPL554) 0.75 mg twice daily plus placebo, in addition to tiotropium" (1 trials), "Ensifentrine (formerly RPL554) 1.5 mg twice daily plus placebo, in addition to tiotropium" (1 trials), "Ensifentrine (formerly RPL554) 3.0 mg twice daily plus placebo, in addition to tiotropium" (1 trials) and "Ensifentrine (formerly RPL554) placebo twice daily, in addition to tiotropium" (1 trials). Other intervention names were less common.

The vast majority of trials in "VitaLink Research - Easley" are 2 trials for "All" genders.

Currently, there are NaN active trials in "VitaLink Research - Easley". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in VitaLink Research - Easley, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in VitaLink Research - Easley, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".